Skip to content

Biorelate vs Data4Cure, Inc.

Biorelate logo

Biorelate

The most advanced data curation in biopharma. Galactic AI™ is powered by the best of LLM, AI and NLP technology

38 employees · est. 2014 · Manchester, United Kingdom

VS
Data4Cure, Inc. logo

Data4Cure, Inc.

Biomedical Intelligence. Turning data into cures

27 employees · est. 2013 · Cambridge, United States

Data4Cure, Inc. is the older company (2014 vs 2013).

Side-by-Side Comparison

Biorelate Data4Cure, Inc.
Founded
2014 2013 older
Headquarters
Manchester, United Kingdom Cambridge, United States
Employees
38 27
Industry
Big Data, Biotechnology, Health Care AI, Analytics, Biotechnology
Funding Stage
Series A Series A
Total Funding
$7.30M $800.00K
Funding Rounds
3 2
Services
Galactic AI platform, data curation services, knowledge graph construction, bioinformatics support Biomedical Intelligence Cloud, CURIE Knowledge Graph, Semantically Harmonized Data Integration, Advanced Data Analysis, AI-Driven Insight Generation
Target Customers
pharmaceutical companies, biotech firms, biologists, data scientists, information managers Pharmaceutical Companies, Biotech Organizations, Clinical Researchers, Research Organizations
Taxonomy
Data CurationBiopharmaceuticalsKnowledge GraphBiomedical ResearchAI TechnologyNatural Language Processing +9 Biomedical AIData IntegrationSemantic Data AnalyticsKnowledge SynthesisDrug DiscoveryBiotech Solutions +9
Website
biorelate.com data4cure.com
Biorelate logo

About Biorelate

Biorelate, founded in 2014 and headquartered in the United Kingdom, is a key player in the intersection of Big Data, Biotechnology, Health Care, and Life Sciences. Their slogan, "The most advanced data curation in biopharma. Galactic AI™ is powered by the best of LLM, AI and NLP technology.", encaps...

Data4Cure, Inc. logo

About Data4Cure, Inc.

Data4Cure, Inc., founded in 2013 in the United States, is at the forefront of applying AI to biomedical challenges under the slogan, “Biomedical Intelligence. Turning data into cures.” Primarily operating within the AI, Analytics, Biotechnology, Education, Health Care, and Life Sciences domains, the...

Also comparing in this category

Comparing more than these two?

Get Biorelate, Data4Cure, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Biorelate compare?

A PDF of Biorelate and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Biorelate was founded in 2014, based in Manchester, United Kingdom, with 38 employees. Biorelate, founded in 2014 and headquartered in the United Kingdom, is a key player in the intersection of Big Data, Biotechnology, Health Care, and Life Sciences. Their slogan, "The most advanced dat. Data4Cure, Inc. was founded in 2013, based in Cambridge, United States, with 27 employees. Data4Cure, Inc., founded in 2013 in the United States, is at the forefront of applying AI to biomedical challenges under the slogan, “Biomedical Intelligence. Turning data into cures.” Primarily opera.
Biorelate has raised $7.30M and Data4Cure, Inc. $800.00K. Latest stage: Biorelate Series A, Data4Cure, Inc. Series A.
Both work in Biotechnology, Health Care and Life Sciences.

Compare Biorelate with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Biorelate on 15 Jun 2026, and Data4Cure, Inc. on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout